Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DCPrime, Janssen in Vax Research Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

DCPrime, Janssen in Vax Research Alliance

Will utilize DCOne technology in feasibility studies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DCPrime BV has entered into a research and optional license agreement with Janssen Pharmaceuticals, in conjunction with the Johnson & Johnson London Innovation Centre, where a team of business and science members identify and build novel early-stage collaborations with emerging companies.
 
Janssen will utilize DCPrime’s DCOne technology in feasibility studies for the development of a dendritic cell-based vaccine for which it will have the option to further develop towards regulatory approval.
 
“DCPrime is always looking for new opportunities for our DCOne technology,” said Marcel Zwaal, chief executive officer of DCPrime. “We are very excited to be able to work with Janssen and it will enable us to further extend the use our vaccine products.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics